Search by Drug Name or NDC

    NDC 44911-0703-01 Mitochondria PRO 16; 12; 12; 6; 12; 6; 30; 12; 35; 30; 30; 30; 12; 12; 30; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h Details

    Mitochondria PRO 16; 12; 12; 6; 12; 6; 30; 12; 35; 30; 30; 30; 12; 12; 30; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h

    Mitochondria PRO is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Energique, Inc.. The primary component is ACONITIC ACID, (Z)-; ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMERICAN GINSENG; ANHYDROUS CITRIC ACID; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM .

    Product Information

    NDC 44911-0703
    Product ID 44911-0703_9afcd035-6123-4574-9c5d-85d7c85b0a8d
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Mitochondria PRO
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aralia Quinquefolia, Arnica Montana, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Ascorbicum Acidum, Alpha-Lipoicum Acidum, Calcarea Carbonica, Citricum Acidum, Cuprum Metallicum, Cysteinum, Ferrum Metallicum, Iodium, Levothyroxinum,
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 16; 12; 12; 6; 12; 6; 30; 12; 35; 30; 30; 30; 12; 12; 30; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12
    Active Ingredient Units [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h
    Substance Name ACONITIC ACID, (Z)-; ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMERICAN GINSENG; ANHYDROUS CITRIC ACID; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM
    Labeler Name Energique, Inc.
    Pharmaceutical Class Acidifying Activity [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine
    DEA Schedule n/a
    Marketing Category UNAPPROVED HOMEOPATHIC
    Application Number n/a
    Listing Certified Through 2025-12-31

    Package

    NDC 44911-0703-01 (44911070301)

    NDC Package Code 44911-0703-1
    Billing NDC 44911070301
    Package 30 mL in 1 BOTTLE, DROPPER (44911-0703-1)
    Marketing Start Date 2023-12-28
    NDC Exclude Flag N
    Pricing Information N/A
    << 44911-0702-01 44924-0901-01 >>

    Contents